CD155, also known as poliovirus receptor (PVR), and poliovirus receptor-related 2, also known as CD112 or nectin-2, are expressed on a variety of tumor tissues, including leukemias [129], ovarian cancer [130], neuroblastoma [131], melanoma [132], and glioblastoma [133]. This evidence concerns the gene NECTIN2 and ovarian carcinoma.